• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21959 Records] Selected Records [0 Hits] [Clear]
Year Source Title
1994     The Swedish Council on Health Technology Assessment (SBU) The treatment and rehabilitation of traffic accident victims
1993     University of York The treatment of depression in primary care
2021     Swiss Federal Office of Public Health (FOPH) The treatment of hypercholesterolaemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines
1992     University of York The treatment of persistent glue ear in children
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) The treatment of primary hypercholesterolaemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines
2000     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) The treatment of venous leg ulcers and optimal use of Apligraf (TM)
2021     NIHR Health Services and Delivery Research programme The TRECA study: TRials Engagement in Children and Adolescents
2006     Alberta Heritage Foundation for Medical Research (AHFMR) The triangle of enhancement medicine, disabled people, and the concept of health: a new challenge for HTA, health research, and health policy
2004     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) The TUNA(R) medical device (Transurethral needle ablation) for the treatment of benign prostatic hyperplasia - preliminary report
2018     NIHR Health Technology Assessment programme The UK EndoVascular Aneurysm Repair (EVAR) randomised controlled trials: long-term follow-up and cost-effectiveness analysis
2012     NIHR Health Technology Assessment programme The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy
2016     NIHR Health Technology Assessment programme The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
2022     NIHR Health Technology Assessment programme The United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) Trial
2014     NIHR Health Services and Delivery Research programme The use of a collaborative structured methodology for the development of a multifaceted intervention programme for the management of asthma (the MIA project), tailored to the needs of children and families of South Asian origin: a community-based, participatory study
1998     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) The use of abciximab (c7E3 Fab) as a therapeutic adjunct to transluminal coronary balloon angioplasty - systematic review
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of anti-D prophylaxis for rhesus negative women in pregnancy
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of atypical antipsychotics for schizophrenia
2005     National Institute for Clinical Excellence (NICE) The use of autologous chondrocyte implantation for the treatment of cartilage defects in knee joints
2005     Quality Improvement Scotland (NHS QIS ) The use of autologous chondrocyte implantation for the treatment of cartilage defects in knee joints (review)
2005     Quality Improvement Scotland (NHS QIS ) The use of B-type natriuretic peptides in the investigation of patients with suspected heart failure; Understanding our Advice: The use of B-type natriuretic peptides in the investigation of patients with suspected heart failure
2002     Canadian Task Force on Preventive Health Care (CTFPHC) The use of back belts for prevention of occupational low back pain: systematic review and recommendations
2010     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2012     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2012     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticularcourse juvenile idiopathic arthritis - a systematic review update
2001     Centre for Clinical Effectiveness (CCE) The use of birth stools during second stage labour and the risk of perineal trauma
2010     Penn Medicine Center for Evidence-based Practice (CEP) The use of bispectral index monitoring for patients receving therapeutic hypothermia
2004     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of biventricular pacemakers at the McGill University Health Centre
2003     Quality Improvement Scotland (NHS QIS ) The use of capecitabine and tegafur with uracil for metastatic colorectal cancer
2003     Quality Improvement Scotland (NHS QIS ) The use of capecitabine for the treatment of locally advanced or metastatic breast cancer
2016     NIHR Health Services and Delivery Research programme The use of cardiac rehabilitation services to aid the recovery of patients with bowel cancer: a pilot randomised controlled trial with embedded feasibility study
2005     Quality Improvement Scotland (NHS QIS ) The use of cardiac resynchronization therapy (CRT) for heart failure
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of computerized cognitive-behavioural therapy for anxiety and depression
2003     Quality Improvement Scotland (NHS QIS ) The use of coronary artery stents
2007     Quality Improvement Scotland (NHS QIS ) The use of cranial orthosis treatment for infant deformational plagiocephaly
2001     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of cyclo-oxygenase (Cox) II selective inhibitors for osteoarthritis and rheumatoid arthritis
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) The use of dental crowns for vital and endodontically treated teeth: a review of the clinical and cost-effectiveness and guidelines
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of drugs for early thrombolysis in the treatment of acute myocardial infarction
2008     NIHR Health Technology Assessment programme The use of economic evaluations in NHS decision-making: a review and empirical investigation
1996     Alberta Heritage Foundation for Medical Research (AHFMR) The use of electrical stimulation to promote healing of fractures
2003     Quality Improvement Scotland (NHS QIS ) The use of electroconvulsive therapy
2003     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) The use of electroconvulsive therapy in Quebec
2001     National Institute for Clinical Excellence (NICE) The use of electronic fetal monitoring. The use and interpretation of cardiotocography in intrapartum fetal surveillance - guideline
2024     Belgian Health Care Knowledge Centre (KCE) The use of endothelial cell counting in the preoperative evaluation of cataract surgery (Study 2023-12)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) The use of endotracheal tubes with subglottic secretion drainage to prevent ventilator-associated pneumonia: clinical effectiveness and safety
2005     Agency for Healthcare Research and Quality (AHRQ) The use of episiotomy in obstetrical care: a systematic review
2006     Quality Improvement Scotland (NHS QIS ) The use of epoetin alfa before orthopaedic surgery in patients with mild anaemia. Understanding our advice: the use of epoetin alfa before orthopaedic surgery in patients with mild anaemia
2001     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of etanercept and infliximab for the treatment of rheumatoid arthritis
2001     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of etanercept for the treatment of juvenile idiopathic arthritis
2016     NIHR Health Technology Assessment programme The use of exploratory analyses within the National Institute for Health and Care Excellence single technology appraisal process: an evaluation and qualitative analysis
2016     NIHR Health Technology Assessment programme The use of exploratory analyses within the NICE single technology appraisal process
2014     NIHR Health Technology Assessment programme The use of fenestrated and branched endovascular aneurysm repair (fEVAR & bEVAR) for juxta-renal and thoraco-abdominal aneurysms: a systematic review and cost effectiveness analysis
2014     NIHR Health Technology Assessment programme The use of fenestrated and branched endovascular aneurysm repair for juxtarenal and thoracoabdominal aneurysms: a systematic review and cost-effectiveness analysis
2017     NIHR Health Technology Assessment programme The use of fibrin sealant during non-emergency surgery: a systematic review of evidence of benefits and harms
2001     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of fludarabine for B-cell chronic lymphocytic leukaemia
2008     Quality Improvement Scotland (NHS QIS ) The use of functional electrical stimulation (FES) in adults with dropped foot
2012     Scottish Health Technologies Group (SHTG) The use of functional electrical stimulation (FES) in adults with dropped foot. This evidence note updates evidence note 25 published in October 2008
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) The use of G-CSF in the prevention of febrile neutropenia
2001     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of gemcitabine (Gemzar) for the treatment of pancreatic cancer
2003     Quality Improvement Scotland (NHS QIS ) The use of glitazones for the treatment of type 2 diabetes
2000     Health Technology Advisory Committee (HTAC) The use of human growth hormone for children with idiopathic short stature
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of human growth hormone in children with growth failure
2004     Medical Services Advisory Committee (MSAC) The use of human papillomavirus testing to monitor effectiveness of treatment of high-grade intraepithelial abnormalities of the cervix
2015     Medical Services Advisory Committee (MSAC) The use of Image Guided Radiation Therapy (IGRT) in the treatment of cancer
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of image-free computer-assisted systems in total knee replacement surgeries
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of imatinib for chronic myeloid leukaemia
2003     Quality Improvement Scotland (NHS QIS ) The use of imatinib for chronic myeloid leukaemia
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of infliximab for Crohn's disease
2014     HAYES, Inc. The use of Information Communication Technology (ICT) to improve treatment adherence in patients with diabetes
2001     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of inhaler devices for routine treatment of chronic asthma in older children
2005     Medical Services Advisory Committee (MSAC) The use of INR point-of-care testing in general practice
2015     Medical Services Advisory Committee (MSAC) The use of Intensity Modulated Radiation Therapy (IMRT) in the treatment of cancer
1999     Wessex Institute for Health Research and Development (WIHRD) The use of interferon alfa in the treatment of metastatic cutaneous melanoma
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer
2008     NIHR Health Technology Assessment programme The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation (review of NICE Guidance No. 33)
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of Lactobacillus probiotics in the prevention of antibiotic associated clostridium difficile diarrhea
2003     Quality Improvement Scotland (NHS QIS ) The use of liquid-based cytology for cervical screening (review)
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of long-acting insulin analogues for the treatment of diabetes - insulin glargine
2001     Alberta Heritage Foundation for Medical Research (AHFMR) The use of low level laser therapy in wound care in Alberta, Canada: results of a survey of physical therapists involved in rehabilitation, long term care and home care
2001     Centre for Clinical Effectiveness (CCE) The use of magnets in the alleviation of chronic muscular pain
2004     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of matrix coils in the treatment of cerebro-vascular aneurysms
2015     NIHR Health Technology Assessment programme The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) The use of medical marijuana: guidelines and recommendations
2012     NIHR Health Technology Assessment programme The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS)
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of metal on metal hip resurfacing
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of mitoxantrone in the treatment of patients with multiple sclerosis: report update
2004     NIHR Health Technology Assessment programme The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis
2005     Quality Improvement Scotland (NHS QIS ) The use of multislice computed tomography angiography (CTA) for the diagnosis of coronary artery disease
1996     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) The use of nitrates in chronic stable angina
1998     Wessex Institute for Health Research and Development (WIHRD) The use of olanzapine as a first and second choice treatment in schizophrenia
1998     West Midlands Health Technology Assessment Collaboration (WMHTAC) The use of olanzapine as a first and second choice treatment in schizophrenia
2003     Quality Improvement Scotland (NHS QIS ) The use of oseltamivir and amantadine for the prophylaxis of influenza
2009     NIHR Health Technology Assessment programme The use of paclitaxel in the management of early stage breast cancer
2003     Quality Improvement Scotland (NHS QIS ) The use of paclitaxel in the treatment of ovarian cancer (review)
2003     Quality Improvement Scotland (NHS QIS ) The use of patient education models for diabetes
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of pegylated liposomal doxorubicin hydrochloride (Caelyx) for ovarian cancer
2003     Quality Improvement Scotland (NHS QIS ) The use of photodynamic therapy for age-related macular degeneration
2005     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of probiotics in the prevention and treatment of clostridium difficile diarrhea
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) The use of probiotics in the prevention and treatment of clostridium difficile diarrhea: an update
2012     Belgian Health Care Knowledge Centre (KCE) The use of Qualitative Research Methods in KCE studies
2007     Quality Improvement Scotland (NHS QIS ) The use of recombinant factor VIIa (rFVIIa) in people with haemophilia who develop inhibitors